The “magic bullet” theory stated by Paul Ehrlich more than one century ago foresees that drugs need to reach their target to exert their pharmacological activity. When dealing with antibiotics, this implies not only a capacity to interact with bacteria, but also to rejoin them in the infected compartment. The latter property is directly linked to pharmacokinetics.
In this Thesis, we have focused our interest on cellular pharmacokinetics of antibiotics in macrophages, reasoning that (i) this model would be relevant for predicting the access of antibiotics to intracellular bacteria, and (ii) deciphering mechanisms of drug entry, distribution, and efflux in single cells would provide pieces of information applicable to the understanding of general pharmaco-kinetics.
Accumulation and distribution were studied for oritavancin, a semi-synthetic glycopeptide currently in phase III of clinical development. This molecule is characterized by a highly bactericidal activity against staphylococci, including multiresistant strains, which would be of interest for the eradication of the intracellular forms of these bacteria. We show that oritavancin enters macrophages by adsorptive endocytosis and accumulates to very large amounts in lysosomes, with cellular concentrations as high as 300-fold the extracellular ones. Accordingly, it exerts a concentration-dependent bactericidal activity against Staphylococcus aureus multiplying in phagolysosomes. In parallel, however, it also causes morphological and biochemical alterations, characterized by the deposition of material of heterogeneous aspect and the accumulation of phospholipids and cholesterol. These data point to the difficulty of dissociating high cellular accumulation and cellular toxicity and plead for the interest of in vitro models in the evaluation of the intracellular activity of antibiotics, the early assessment of drug safety profile and the orientation of further in vivo studies.
Active efflux was evaluated for macrolides and quinolones, two antibiotic classes accumulating in macrophages and therefore usually considered as useful in the treatment intracellular infections. Macrophages indeed express multidrug transporters in their pericellular membrane, which can extrude a large variety of drugs presenting as common feature an amphiphatic character. We show that macrolides (and azithromycin in particular) are substrates for P-glycoprotein, while quinolones (and ciprofloxacin in particular) are substrates for an MRP-like transporter. Inhibiting these pumps increases the intracellular activity of these antibiotics by enhancing their cellular accumulation. We also describe different mode of transport for these antibiotics, which essentially reflect their variable fluxes through the membrane. These data underline the major role constitutive efflux plays in the modulation of the pharmacokinetics of drugs, and, hence, of their pharmacodynamics. They encourage the setting-up of large-scale screenings aimed at evaluating drug-transporter interactions in lead optimization processes.
We may therefore conclude to the usefulness of cellular models in the study of the pharmacokinetics of drugs and of its consequences for pharmacodynamics and toxicity, and suggest the implementation of such models in the early development of new drugs.
| Identifer | oai:union.ndltd.org:BICfB/oai:ucl.ac.be:ETDUCL:BelnUcetd-10272005-181356 |
| Date | 07 April 2005 |
| Creators | Van Bambeke, Françoise |
| Publisher | Universite catholique de Louvain |
| Source Sets | Bibliothèque interuniversitaire de la Communauté française de Belgique |
| Language | English |
| Detected Language | English |
| Type | text |
| Format | application/pdf |
| Source | http://edoc.bib.ucl.ac.be:81/ETD-db/collection/available/BelnUcetd-10272005-181356/ |
| Rights | unrestricted, J'accepte que le texte de la thèse (ci-après l'oeuvre), sous réserve des parties couvertes par la confidentialité, soit publié dans le recueil électronique des thèses UCL. A cette fin, je donne licence à l'UCL : - le droit de fixer et de reproduire l'oeuvre sur support électronique : logiciel ETD/db - le droit de communiquer l'oeuvre au public Cette licence, gratuite et non exclusive, est valable pour toute la durée de la propriété littéraire et artistique, y compris ses éventuelles prolongations, et pour le monde entier. Je conserve tous les autres droits pour la reproduction et la communication de la thèse, ainsi que le droit de l'utiliser dans de futurs travaux. Je certifie avoir obtenu, conformément à la législation sur le droit d'auteur et aux exigences du droit à l'image, toutes les autorisations nécessaires à la reproduction dans ma thèse d'images, de textes, et/ou de toute oeuvre protégés par le droit d'auteur, et avoir obtenu les autorisations nécessaires à leur communication à des tiers. Au cas où un tiers est titulaire d'un droit de propriété intellectuelle sur tout ou partie de ma thèse, je certifie avoir obtenu son autorisation écrite pour l'exercice des droits mentionnés ci-dessus. |
Page generated in 0.0116 seconds